Shigella flexneri 2a Invaplex 50 vaccine dose finding and assessment of protection
Phase of Trial: Phase I/II
Latest Information Update: 22 Jul 2011
At a glance
- Drugs Shigella flexneri 2A vaccine (Primary)
- Indications Diarrhoea; Dysentery; Fever; Shigella infections
- Focus Pharmacodynamics
- 22 Jul 2011 Results published in Vaccine.
- 01 Dec 2010 Planned end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 01 Dec 2010 Actual initiation date (May 2007) added as reported by ClinicalTrials.gov.